Abstract-3H-Cimetidine binding to plasma membranes of isolated guinea pig gastric glands was investigated, and the effects of five H2-receptor antagonists on 3H-cimetidine binding and histamine stimulation of cellular cAMP were compared . Of the five cations tested, Cu" markedly increased specific 3H-cimetidine binding. 3H-Cimetidine had high affinity (Kd=0 .41 X10-6 M) and low affinity (Kd=12.8x 10-6 M) binding sites. Cimetidine and etintidine were potent inhibitors of 3H cimetidine binding, while famotidine, ranitidine and TZU-0460 were not. Histamine stimulation of cellular cAMP was competitively inhibited by H2-receptor antagonists yielding pA2 values of 6.41 for cimetidine, 6.82 for etintidine, 6.87 for ranitidine, 6.94 for TZU-0460 and 7.60 for famotidine. Because the KB value (log KB=-pA2) of 0.39x10-6 M for cimetidine is close to the Kd value for the high affinity 3H cimetidine binding site, it is presumed to represent a part of the H2-receptor, and the relative potency of etintidine against cimetidine in inhibiting 3H-cimetidine binding
Since burimamide, metiamide and cime tidine had been reported to inhibit gastric acid secretion, it has generally been con cluded that histamine-stimulated acid secretion of the stomach is mediated by a specific class of receptors classified as H2 receptors (1, 2) ; cAM P is regarded as the second messenger for these sites (3) (4) (5) (6) . With the development of new H2-receptor an tagonists, which differ considerably from cimetidine in chemical structure, the concept of the structural requirements for H2 receptor antagonism has changed (7, 8). For further investigation of the H2-receptor, the radioligand binding technique has been used for examination of brain or gastric tissues (9-13). To study parietal cell function at the cellular level, preparations of enriched parietal cells such as isolated gastric glands or isolated parietal cells are often used. In the present work, we compared the inhibitory effect of five H2-receptor antagonists (cime tidine, etintidine, ranitidine, TZU-0460 and famotidine; for structures, see Fig. 1 ) on 3H cimetidine binding and histamine-stimulation of cellular cAMP in isolated guinea pig gastric glands.
Materials and Methods 1) Preparation of isolated gastric glands
Male Hartley albino guinea pigs (300 500 g) were deprived of food for 24 hr and then decapitated.
The fundic region of the stomach was removed and rinsed several times with ice-cold 0.9% NaCI. The fundic mucosa was separated from the muscularis and cut into small pieces using a razor blade. Minced tissue was rinsed three times in oxygenated Hanks' MEM solution (with 0.2% bovine serum albumin, 25 mM HEPES, pH 7.4) and digested with 0.05% collagenase enzyme solution at 37'C. During digestion, the suspension was gently shaken, and gassed continuously with 100% 02. After 20 min of digestion, the suspension was allowed to settle, and the sediment was reincubated with fresh Hanks' MEM solution containing 0.05% collagenase at 37°C. After 20 min of digestion, the suspension of isolated gastric glands was filtered through nylon mesh and rinsed three times with ice cold Hanks' MEM solution.
The average populations of parietal cells, zymogen cells and other cells in the isolated gastric gland were 59.1 ±2.5%, 26.8±1.9% and 1 3.2±1.4% (Mean±S.E., n=15), respectively, as deter mined on the fluorescence micrographs of the isolated gastric glands in the presence of acridine orange (10-4 M). As the exclusion rate of 0.5% trypan blue was over 95%, the viability of isolated gastric glands was good. 2) Preparation of the plasma membranes from isolated gastric glands Using a Teflon-glass homogenizer, the isolated gastric glands were homogenized in 0.25 M sucrose (3 mM Tris-HCI, pH 7.4) and then centrifuged at 700 x g for 10 min. The supernatant was recentrifuged at 45,000 x g for 20 min. After resuspension and recen trifugation had been performed twice, the pellet was gently suspended in 10 mM Tris HCI buffer (pH 7.4). These procedures were carried out at 4°C, and membranes were stored at -20'C. 3) Experimental design i) Cellular cAMP: Isolated gastric glands were suspended in Hanks' MEM solution (0.5-1 mg protein/ml).
After preincubation for 5 min, 1 ml samples of the suspension of isolated gastric glands were incubated with each secretagogue at 37'C for 10 min, and then incubation was halted by cooling the samples at 4°C. Immediately afterwards, the sample was centrifuged at 700 x g for 5 min. The sediments were homogenized by ultra sonic disintegration (20 kHz, 10 sec) and extracted with 0.1 N HCI for cAM P assay. The cAM P assay was carried out using a Yamasa cAM P radioimmunoassay kit. Pro tein content of the gastric glands was deter mined by the method of Lowry et al. (14) . (15) . The Scatchard plot calculated from cimetidine inhibition data was analyzed by least-squares non-linear regression analysis, according to Feldman (16) . ED50 values for histamine dose-response curves with cellular cAM P were calculated from logit-log analysis (17) followed by linear regression analysis. The proportion of specific 3H-cimetidine binding to the high affinity site is calculated on the assumption that both high and low affinity sites obey the simple mass action law (18).
Results

1) 3H-Cimetidine
binding studies: To study the effects of cations on 3H-cimetidine binding, five chloride salts were tested. Of the five chloride salts (CaCI2, CuCI2, MgCI2, KCI, NaCI), CuCI2 remarkably increased specific 3H-cimetidine binding (Fig. 2 ). In the presence of 50 ,uM Cu", the specific 3H-cimetidine binding to the membrane preparations was stable and maximal at 4°C and reached equilibrium within 40 min. On the other hand, the specific 3H-cimetidine binding at 37 and 22°C did not reach the same degree observed by incubation at 4°C for 40 min, and it decreased with the passage of time (Fig. 3) . Therefore, subsequent assays were performed at 4°C for 60 min in the presence of 50 /1M Cu". The binding of 3H -cimetidine to the membrane preparations was reversible by the addition of an excess of unlabelled cimetidine, and boiling the mem branes for 10 min prior to the binding study reduced specific 3H-cimetidine binding to about one-tenth.
Inhibition by unlabelled cimetidine of 3H cimetidine binding gave a rather flat curve with a pseudo Hill coefficient of less than unity (n1; 0.76±0.10; n=6), and it resulted in a hyperbolic Scatchard plot which could be separated into two linear components, as suming two classes of binding sites: high affinity and low affinity (Fig. 4) . The high affinity binding site had a Kdl of 0.41±0.1 x10-6 M and a B1T 1ax1 of 265±67 pmol/mg protein, while the low affinity binding site had a Kd2 of 12.8±4.6 x 10-6 M and a Bmax2 of 4,030±880 pmol/mg protein. For com parative purposes, a Scatchard plot of the inhibition of 3H-cimetidine by unlabelled cimetidine at 37°C for 10 min (nrr 0.6±0.11 n=3) was prepared. Two components could be distinguished.
At a temperature of 37'C, Kd and Bmax values for the high affinity binding site were 0.34±0.29 x 10-6 M and 32.8±26 pmol/mg protein, and those for the low affinity binding site were 33.1 ±14.Ox 10-6 M and 4,128±394 pmol/mg protein, respectively. I n comparison with the study at 4°C, while the Kd value for the high affinity binding site at 37°C was similar, the Bmax value for the high affinity binding site at 37 °C markedly decreased.
Competition experiments were performed with a low concentration of 3H-cimetidine (9 nM) at 4°C, and the potencies of histamine, several newer H2-receptor antagonists (etin tidine, ranitidine, TZU-0460 and famotidine), two Hi-receptor antagonists (mepyramine, diphenhydramine), atropine, imidazole and clonidine, an imidazoline a2-adrenoceptor agonist, to inhibit specific 3H-cimetidine If the potency of cimetidine to inhibit 3H-cimetidine binding is assigned a value of 100, the relative potencies were as follows: cimetidine, 100; etintidine, 360; and famotidine, 4 (calculated from apparent IC50 values).
2) Cellular cAM P studies: To explore the correlation between antagonist affinity found in the binding study and antagonist potency obtained in pharmacological tests, the effects of H2-antagonists on the histamine-stimu lation of cellular cAMP were investigated. Histamine caused a 11.7-fold increase in cellular cAMP (basal 4.3±0.9 pmol/mg protein, maximum 49.7±4. 4 pmol/mg pro tein), with a half maximal increase oc curring at 6.3x 10-5 M histamine (n=16). Cimetidine did not alter cAMP in control glands, but caused a parallel rightward shift in the dose response curve for histamine, and with a sufficiently high concentration of histamine, the inhibition caused by cimeti dine was abolished, thereby indicating a simple competitive antagonism. The shift of the dose-response curve for histamine was analyzed by the method of Arunlakshana and Schild (19). The slope of the regression line (with the 95% confidence limits) was 0.99 (0.86-1.11) (Fig. 6) . Similar results were obtained with etintidine, ranitidine, famo tidine and TZU-0460. All antagonists showed competitive inhibition against histamine stimulation of cellular cAMP, since the slopes of the regression line describing log (DR-1), as a function of log antagonist concentration, were not significantly different from unity. Furthermore, the calculated affinities of the newer antagonists for the receptor were X-intercept gives a pA2 value. Values were computed as described in the legend of Fig. 6 , and 95% confidence limits are given, higher than that of cimetidine (Table 2) . If the potency of cimetidine in inhibiting the histamine-stimulation of cellular cAMP is assigned a value of 100, the relative potencies of these antagonists were as follows: cimetidine, 100; etintidine, 250; ranitidine, 280; TZU-0460, 360; and famotidine, 1300 (calculated from KB values).
Discussion
We have demonstrated specific 3H cimetidine binding sites in membrane pre parations of isolated guinea pig gastric glands in the presence of Cu", at concen trations similar to those in the blood (50 ,uM) (11). Greenaway et al. (20) reported that cimetidine reacts with Cu" to produce the Cu"-cimetidine complexes which may increase specific cimetidine binding. Specific 3H-cimetidine binding was maximal and stable at 4°C. For this reason, in the present study, we studied the reversibility, saturability and drug specificity of 3H-cimetidine binding at a temperature of 4°C, although ligand binding studies should be done at a tempera ture close to 37°C. Non-specific binding was measured in the presence of unlabelled 10-4 M cimetidine. 3H-cimetidine binding was no longer decreased by unlabelled cimetidine over the concentration of 10-4 M when the concentration of 3H-cimetidine was 9 nM. Scatchard plot analysis revealed two classes of binding sites. To obtain apparent IC50 values for drugs in 3H-cimetidine binding to the high affinity sites, competition experi ments were performed with a low concen tration of 3H-cimetidine (9 nM). Under these conditions, 3H-cimetidine binding to the high affinity site was estimated from saturation data to represent 67% of the total specific binding, and imidazole-derived H2_ antagonists (cimetidine and etintidine) were most potent in inhibiting 3H-cimetidine binding, and histamine and famotidine were more potent than other drugs. A very potent and specific agonist for histamine H2 receptor has been synthesized (8), but the only H2-receptor agonist used in the present study was histamine.
As a physiological or pharmacological response is essential for defining a receptor, experiments should be done to correlate the drug affinity found in the binding study with the drug potency obtained in pharmacological tests, performed either in vivo or in vitro. The responses mediated by the histamine H2 receptor are atrial contraction, relaxation of the rat uterus and stimulation of gastric acid secretion (1) , and discrepancies between the affinities for the H2-receptor antagonists in various H2-receptor preparations and animals has been reported (2, 21) . Because of the difficulty in directly measuring acid secretion from isolated gastric glands or parietal cells, changes in cellular cAMP, as an index for the acid secretory response, were used in the present study. Gastric glands are composed of a few types of cells. Berglindh and Oblink (22) also reported that four types of cells could be identified among isolated rabbit gastric glands: parietal cells, zymogen cells, mucous neck cells and some endocrine cells. Although dispersed gastric mucosal cells or isolated gastric glands contain, more or less, non parietal cells, the histamine stimulated adenylate cyclase system is presumed to be located in the parietal cell component (23, 24). We used five H2-receptor antagonists, all with different structures, i.e., cimetidine and etintidine (an imidazole derivative), ranitidine (a furan derivative) famotidine (a thiazole derivative) and TZU-0460 (a benzene derivative). TZU-0460, in particular, differs considerably in chemical structure from other H2-receptor antagonists. Although it has been suggested that the critical structural feature of the H2-receptor antago nist is the imidazole ring (7) or ethylthio methyl ring-side chain of various guanidine derivatives (8), TZU-0460 has neither of these components (Fig. 1) . Rising et al. (11) suggested that 3H cimetidine might not label the H2-receptor in the guinea pig cerebral cortex and gastric mucosa membrane preparations.
In their experiments, the K,, values for 3H-cimetidine did not correspond to the KB value for cimetidine, calculated from pharmacological tests. Gillian et al. (13) reported that 3H tiotidine met the criteria for labelling of the H2-receptor in the guinea pig cerebral cortex, but they could not demonstrate specific 3H tiotidine binding in other tissues regarded as having H2-receptors (guinea pig gastric mucosa and right atrium and rat uterus and cerebral cortex). Maayani et al. (25) also failed to demonstrate specific 3H-tiotidine binding in the rat hippocampus and postulated that 3H-tiotidine is useless for labelling the H2-receptor in a binding study. On the other hand, Kendall et al. (10) reported that in the presence of Cull, 3H-cimetidine might be labelling a biologically relevant H2 binding site in rat brain membrane fractions. In our experiments, the KB value for cimetidine was close to the Kd value for the high affinity 3H cimetidine binding site, and the relative potency of etintidine against cimetidine in inhibiting 3H-cimetidine binding is similar to the relative potency of etintidine against cimetidine in inhibiting histamine stimulation of cellular cAMP (360:100, 250:100, respec tively). From these results, 3H-cimetidine seems to be labelling a part of the H2 receptor. However, the question arises as to why non-imidazole H2-receptor antagonists which showed more potent inhibitory effects than cimetidine on histamine-stimulation of cellular cAMP were less potent inhibitors of 3H-cimetidine binding . Although Smith et al. (12) concluded that the 3H-cimetidine binding site in rat brain tissue is not the histamine H2-receptor, because of the lack of inhibition observed by non-imidazole H2 receptor antagonists, we suggest a different hypothesis. Binding subunits of the H2 receptor may explain the weak inhibition of 3H-cimetidine binding by non-imidazole H2 receptor antagonists. Multiple binding sites for agonists and antagonists on the acetylcholine receptor have been postulated (26). With respect to the histamine H2-receptor, Hersey (27) suggested that the H2-receptor molecule has at least three critical binding sites for agonists and antagonists; whereas histamine binds to all sites, other agonists do not. Weinstein et al. (28) assumed that the pro tonated amine side chain of histamine binds to the anionic site I of the H2-receptor and the imidazole ring to sites II and III by hydrogen bonding. In such a receptor model with multiple binding sites for an agonist, it may be that the binding site for one antago nist is not identical with that for another antagonist of a different chemical structure. Bristow et al. (9) reported that even at high concentrations, cimetidine could not inhibit 3H -ranitidine binding and ranitidine could not inhibit 3H-cimetidine binding in the guinea pig heart membrane preparations. The present study suggests that histamine may bind to the H2-receptor of gastric glands at several sites and that imidazole-derived H2-receptor antagonists and non-imidazole derived H2 receptor antagonists compete with histamine at different sites on the H2-receptor.
